99 related articles for article (PubMed ID: 17239995)
1. Genetic study evaluating LDLR polymorphisms and Alzheimer's disease.
Lämsä R; Helisalmi S; Herukka SK; Tapiola T; Pirttilä T; Vepsäläinen S; Hiltunen M; Soininen H
Neurobiol Aging; 2008 Jun; 29(6):848-55. PubMed ID: 17239995
[TBL] [Abstract][Full Text] [Related]
2. Study on the association between SOAT1 polymorphisms, Alzheimer's disease risk and the level of CSF biomarkers.
Lamsa R; Helisalmi S; Herukka SK; Tapiola T; Pirttila T; Vepsalainen S; Hiltunen M; Soininen H
Dement Geriatr Cogn Disord; 2007; 24(2):146-50. PubMed ID: 17622762
[TBL] [Abstract][Full Text] [Related]
3. Association of prostaglandin-endoperoxide synthase 2 (PTGS2) polymorphisms and Alzheimer's disease in Chinese.
Ma SL; Tang NL; Zhang YP; Ji LD; Tam CW; Lui VW; Chiu HF; Lam LC
Neurobiol Aging; 2008 Jun; 29(6):856-60. PubMed ID: 17234302
[TBL] [Abstract][Full Text] [Related]
4. Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease.
Helisalmi S; Tarvainen T; Vepsäläinen S; Koivisto AM; Hiltunen M; Soininen H
Neurosci Lett; 2008 Aug; 441(2):233-6. PubMed ID: 18573313
[TBL] [Abstract][Full Text] [Related]
5. Association study of the paraoxonase 1 gene with the risk of developing Alzheimer's disease.
Chapuis J; Boscher M; Bensemain F; Cottel D; Amouyel P; Lambert JC
Neurobiol Aging; 2009 Jan; 30(1):152-6. PubMed ID: 17624629
[TBL] [Abstract][Full Text] [Related]
6. Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease.
Helisalmi S; Väkevä A; Hiltunen M; Soininen H
Dement Geriatr Cogn Disord; 2009; 27(4):318-21. PubMed ID: 19293566
[TBL] [Abstract][Full Text] [Related]
7. Age-dependent association of KIBRA genetic variation and Alzheimer's disease risk.
Rodríguez-Rodríguez E; Infante J; Llorca J; Mateo I; Sánchez-Quintana C; García-Gorostiaga I; Sánchez-Juan P; Berciano J; Combarros O
Neurobiol Aging; 2009 Feb; 30(2):322-4. PubMed ID: 17707552
[TBL] [Abstract][Full Text] [Related]
8. Genetic association of low density lipoprotein receptor and Alzheimer's disease.
Gopalraj RK; Zhu H; Kelly JF; Mendiondo M; Pulliam JF; Bennett DA; Estus S
Neurobiol Aging; 2005 Jan; 26(1):1-7. PubMed ID: 15585340
[TBL] [Abstract][Full Text] [Related]
9. Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease.
Depboylu C; Lohmüller F; Du Y; Riemenschneider M; Kurz A; Gasser T; Müller U; Dodel RC
Neurosci Lett; 2006 Jun; 400(3):187-90. PubMed ID: 16650578
[TBL] [Abstract][Full Text] [Related]
10. Variations in the APP gene promoter region and risk of Alzheimer disease.
Guyant-Maréchal L; Rovelet-Lecrux A; Goumidi L; Cousin E; Hannequin D; Raux G; Penet C; Ricard S; Macé S; Amouyel P; Deleuze JF; Frebourg T; Brice A; Lambert JC; Campion D
Neurology; 2007 Feb; 68(9):684-7. PubMed ID: 17325276
[TBL] [Abstract][Full Text] [Related]
11. Influence of SORL1 gene variants: association with CSF amyloid-beta products in probable Alzheimer's disease.
Kölsch H; Jessen F; Wiltfang J; Lewczuk P; Dichgans M; Kornhuber J; Frölich L; Heuser I; Peters O; Schulz JB; Schwab SG; Maier W
Neurosci Lett; 2008 Jul; 440(1):68-71. PubMed ID: 18541377
[TBL] [Abstract][Full Text] [Related]
12. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
[TBL] [Abstract][Full Text] [Related]
13. Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer's disease.
Wang B; Jin F; Xie Y; Tang Y; Kan R; Zheng C; Yang Z; Wang L
Neurosci Lett; 2006 Dec; 409(3):179-81. PubMed ID: 17027152
[TBL] [Abstract][Full Text] [Related]
14. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.
Yao L; Li K; Zhang L; Yao S; Piao Z; Song L
Brain Res; 2009 Sep; 1291():133-9. PubMed ID: 19631630
[TBL] [Abstract][Full Text] [Related]
15. Association of SORL1 gene variants with Alzheimer's disease.
Kölsch H; Jessen F; Wiltfang J; Lewczuk P; Dichgans M; Teipel SJ; Kornhuber J; Frölich L; Heuser I; Peters O; Wiese B; Kaduszkiewicz H; van den Bussche H; Hüll M; Kurz A; Rüther E; Henn FA; Maier W
Brain Res; 2009 Apr; 1264():1-6. PubMed ID: 19368828
[TBL] [Abstract][Full Text] [Related]
16. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
Hong GS; Heun R; Jessen F; Popp J; Hentschel F; Kelemen P; Schulz A; Maier W; Kölsch H
Neurobiol Aging; 2009 May; 30(5):691-6. PubMed ID: 17904251
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease. The Rotterdam Study.
Reitz C; van Rooij FJ; de Maat MP; den Heijer T; Hofman A; Witteman JC; Breteler MM
Neurobiol Aging; 2008 Jun; 29(6):874-81. PubMed ID: 17316907
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in the glucocorticoid receptor gene (NR3C1) and cardiovascular disease risk. The Leiden 85-plus Study.
Kuningas M; Mooijaart SP; Slagboom PE; Westendorp RG; van Heemst D
Biogerontology; 2006 Aug; 7(4):231-8. PubMed ID: 16676134
[TBL] [Abstract][Full Text] [Related]
19. Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients.
Guidi I; Galimberti D; Venturelli E; Lovati C; Del Bo R; Fenoglio C; Gatti A; Dominici R; Galbiati S; Virgilio R; Pomati S; Comi GP; Mariani C; Forloni G; Bresolin N; Scarpini E
Neurobiol Aging; 2005 Jun; 26(6):789-94. PubMed ID: 15718036
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
